Trial Profile
SHO-SAIKO-TO for Patients With Chronic Hepatitis C Who Are Intolerant to or Have Contraindication to Interferon-Based Therapy: A Phase II Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jan 2016
Price :
$35
*
At a glance
- Drugs TJ 9 (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 09 Jun 2014 New trial record